Entrada Therapeutics
204 employees
Biotech/Pharma
Public · $175.0M
Open positions (5)
Company details
Team Size204
IndustryBiotech/Pharma
Funding
Total raised
$175.0M
Last stage
Public
Investors
Wellington Management
Total raised
$175.0M
Last stage
Public
Investors
Dehua Pei
Professor at The Ohio State University; scientific founder whose lab research forms the basis of Entrada's intracellular biologics platform.
Leo Qian
Co-founded Entrada Therapeutics in 2016.
Dipal Doshi
Joined Entrada in 2017 as its first full-time employee; previously President & CEO from 2017–2024. Former Chief Business Officer at Amicus Therapeutics. Holds an MBA from The Wharton School.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.